Who Holds ARS Pharmaceuticals, Inc. (SPRY)? 206 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 206 holders, $707 million in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10,860,977 | $87 million | +0% | 13F |
| Rubric Capital Management LP | 8,540,861 | $68 million | +7% | 13F |
| ORBIMED ADVISORS LLC | 8,288,510 | $66 million | +0% | 13F |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7,503,812 | $60 million | +0% | 13F |
| BlackRock, Inc. | 5,311,319 | $43 million | +6% | 13F |
| Tyro Capital Management LLC | 4,459,337 | $36 million | +50% | 13F |
| Aberdeen Group plc | 4,170,629 | $33 million | +1% | 13F |
| SR One Capital Management, LP | 4,012,903 | $32 million | +0% | 13F |
| STATE STREET CORP | 3,730,623 | $30 million | +2% | 13F |
| Capital World Investors | 2,754,931 | $22 million | New | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,553,528 | $20 million | +0% | 13F |
| MILLENNIUM MANAGEMENT LLC | 2,400,937 | $19 million | -60% | 13F |
| UBS Group AG | 1,939,654 | $16 million | -14% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 1,699,017 | $14 million | +11% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,601,504 | $13 million | +539% | 13F |
| GENERAL AMERICAN INVESTORS CO INC | 1,133,046 | $9 million | +56% | 13F |
| Third Point LLC | 1,000,000 | $8 million | +0% | 13F |
| PEREGRINE CAPITAL MANAGEMENT LLC | 672,139 | $5 million | New | 13F |
| Tejara Capital Ltd | 607,039 | $5 million | +189% | 13F |
| ADAR1 Capital Management, LLC | 600,999 | $5 million | -56% | 13F |
| Pavaki Capital Management LLC | 579,600 | $5 million | +1% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 566,829 | $5 million | +11% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551,416 | $4 million | +3% | 13F |
| NORTHERN TRUST CORP | 549,064 | $4 million | +4% | 13F |
| LEVIN CAPITAL STRATEGIES, L.P. | 548,965 | $4 million | -1% | 13F |
| CITADEL ADVISORS LLC | 531,063 | $4 million | -70% | 13F |
| Empire Life Investments Inc. | 471,856 | $4 million | -5% | 13F |
| BANK OF AMERICA CORP /DE/ | 463,256 | $4 million | +62% | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 461,384 | $4 million | -1% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 461,001 | $4 million | +3% | 13F |
| FIL Ltd | 455,575 | $4 million | +0% | 13F |
| JPMORGAN CHASE & CO | 363,316 | $3 million | -5% | 13F |
| GOLDMAN SACHS GROUP INC | 380,770 | $3 million | -47% | 13F |
| Eversept Partners, LP | 377,007 | $3 million | +177% | 13F |
| K2 PRINCIPAL FUND, L.P. | 375,132 | $3 million | -33% | 13F |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 373,491 | $3 million | +4% | 13F |
| FMR LLC | 349,164 | $3 million | +2% | 13F |
| RAYMOND JAMES FINANCIAL INC | 318,583 | $3 million | -39% | 13F |
| Trexquant Investment LP | 286,733 | $2 million | New | 13F |
| Jump Financial, LLC | 255,200 | $2 million | New | 13F |
| MORGAN STANLEY | 229,100 | $2 million | -28% | 13F |
| FAS Wealth Partners, Inc. | 214,507 | $2 million | +4% | 13F |
| Hennion & Walsh Asset Management, Inc. | 175,614 | $1 million | New | 13F |
| Quinn Opportunity Partners LLC | 175,000 | $1 million | +13% | 13F |
| Bank of New York Mellon Corp | 168,136 | $1 million | +2% | 13F |
| DAFNA Capital Management LLC | 164,285 | $1 million | +18% | 13F |
| Nuveen, LLC | 161,342 | $1 million | +7% | 13F |
| Ishara Investments LP | 143,490 | $1 million | New | 13F |
| Engineers Gate Manager LP | 139,419 | $1 million | +195% | 13F |
| Steward Partners Investment Advisory, LLC | 128,600 | $1 million | -12% | 13F |
| BARCLAYS PLC | 126,261 | $1 million | +50% | 13F |
| AMERICAN ASSETS INC | 125,000 | $1 million | +1686% | 13F |
| Quantinno Capital Management LP | 124,429 | $996,676 | +23% | 13F |
| MARSHALL WACE, LLP | 123,714 | $990,949 | +18% | 13F |
| CenterBook Partners LP | 123,624 | $990,228 | -58% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 115,523 | $925,339 | -33% | 13F |
| SEI INVESTMENTS CO | 104,643 | $838,190 | +706% | 13F |
| Parkman Healthcare Partners LLC | 102,700 | $822,627 | New | 13F |
| Swiss National Bank | 94,600 | $757,746 | -12% | 13F |
| Corient Private Wealth LP | 91,042 | $729,248 | +12% | 13F |
| CITIGROUP INC | 89,199 | $714,484 | +379% | 13F |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 83,225 | $666,633 | +0% | 13F |
| RHUMBLINE ADVISERS | 75,989 | $608,660 | +5% | 13F |
| Headlands Technologies LLC | 75,279 | $602,985 | +56% | 13F |
| AssuredPartners Investment Advisors, LLC | 73,260 | $586,816 | -4% | 13F |
| XTX Topco Ltd | 73,187 | $586,228 | -73% | 13F |
| Norman Fields, Gottscho Capital Management, LLC | 71,080 | $569,351 | +78% | 13F |
| DEUTSCHE BANK AG\ | 65,866 | $527,587 | +21% | 13F |
| Matisse Capital | 65,701 | $526,265 | -2% | 13F |
| DIKER MANAGEMENT LLC | 65,508 | $525,000 | +95% | 13F |
| Balyasny Asset Management L.P. | 64,658 | $517,911 | +5% | 13F |
| Rafferty Asset Management, LLC | 63,574 | $509,228 | -46% | 13F |
| WELLS FARGO & COMPANY/MN | 62,995 | $504,590 | +107% | 13F |
| VOYA INVESTMENT MANAGEMENT LLC | 60,110 | $481,481 | +3% | 13F |
| ALLIANCEBERNSTEIN L.P. | 59,490 | $477,705 | +42% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 58,413 | $467,888 | -4% | 13F |
| Coastal Bridge Advisors, LLC | 55,838 | $447,262 | +0% | 13F |
| ROYCE & ASSOCIATES LP | 54,024 | $432,732 | +0% | 13F |
| TWO SIGMA INVESTMENTS, LP | 52,400 | $419,724 | New | 13F |
| SCHULHOFF & CO INC | 51,150 | $409,711 | +0% | 13F |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 46,123 | $369,445 | -14% | 13F |
| TUDOR INVESTMENT CORP ET AL | 45,895 | $367,619 | New | 13F |
| Permanent Capital Management, LP | 43,383 | $347,498 | +24% | 13F |
| VANGUARD ASSET MANAGEMENT, Ltd | 40,388 | $323,508 | +0% | 13F |
| LETKO, BROSSEAU & ASSOCIATES INC | 40,050 | $320,801 | +62% | 13F |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 39,579 | $317,028 | +25% | 13F |
| Legal & General Group Plc | 38,988 | $312,490 | -19% | 13F |
| Invesco Ltd. | 38,891 | $311,516 | +2% | 13F |
| MetLife Investment Management, LLC | 36,644 | $293,518 | +7% | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 35,754 | $290,452 | 0% | 13F |
| AQR CAPITAL MANAGEMENT LLC | 35,676 | $285,764 | +38% | 13F |
| Everstar Asset Management, LLC | 33,732 | $270,193 | +69% | 13F |
| VARCOV Co. | 32,945 | $263,889 | +2% | 13F |
| WINTON GROUP Ltd | 32,900 | $263,529 | New | 13F |
| PROFUND ADVISORS LLC | 32,199 | $257,914 | -38% | 13F |
| Verition Fund Management LLC | 30,750 | $246,308 | New | 13F |
| Cresset Asset Management, LLC | 30,152 | $241,518 | +0% | 13F |
| SECTORAL ASSET MANAGEMENT INC | 29,900 | $239,499 | -62% | 13F |
| PRINCIPAL FINANCIAL GROUP INC | 29,727 | $238,113 | New | 13F |
| CANADA PENSION PLAN INVESTMENT BOARD | 29,600 | $237,096 | +0% | 13F |
Questions and answers
- How many institutions hold ARS Pharmaceuticals, Inc.?
- 206 managers reported ARS Pharmaceuticals, Inc. on Form 13F for the quarter ended 30 June 2026, against 203 the quarter before.
- Who is the largest institutional holder of ARS Pharmaceuticals, Inc.?
- RA CAPITAL MANAGEMENT, L.P., with 10,860,977 shares worth $87 million on its 13F for Q2 2026.
- How many institutions bought or sold out of ARS Pharmaceuticals, Inc. in Q2 2026?
- 38 managers reported a new position and 35 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds ARS Pharmaceuticals, Inc., Q2 2026", https://app.tamarly.ai/holders/ars-pharmaceuticals, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.